Human adipose stem cell-conditioned medium increases survival of Friedreich's Ataxia cells submitted to oxidative stress

Stem Cells and Development

Volumn 21, Issue 15, 2012, Pages 2817-2826

  Jones, Jonathan ^a   Estirado, Alicia ^a   Redondo, Carolina ^a   Bueno, Carlos ^a   Martínez, Salvador ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FRATAXIN;

ADIPOSE DERIVED STEM CELL; ARTICLE; CELL CULTURE; CELL DEGENERATION; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; FRIEDREICH ATAXIA; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; UPREGULATION;

ADIPOSE TISSUE; ADULT STEM CELLS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENZYME ACTIVATION; FRIEDREICH ATAXIA; GENE EXPRESSION; HUMANS; HYDROGEN PEROXIDE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OXIDANTS; OXIDATIVE STRESS; PERIODONTAL LIGAMENT; TRANSCRIPTOME; UP-REGULATION;

EID: 84870403700     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0029     Document Type: Article

References (40)

1. Campuzano V, L Montermini, MD Molto, L Pianese, M Cossee, F Cavalcanti, E Monros, F Rodius, F Duclos, et al. (1996). Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423-1427.
2. Campuzano V, L Montermini, Y Lutz, L Cova, C Hindelang, S Jiralerspong, Y Trottier, SJ Kish, B Faucheux, et al. (1997). Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 6:1771-1780.
3. Pandolfo M. (2009). Friedreich's ataxia: the clinical picture. J. Neurol 256:3-8.
4. Schulz JB, S Boesch, K Burk, A Durr, P Giunti, C Mariotti, F Pousset, L Schols, P Vankan and M Pandolfo. (2009). Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol 5:222-234.
5. Alvarez-Dolado M, R Pardal, JM Garcia-Verdugo, JR Fike, HO Lee,KPfeffer,CLois, SJMorrison andAAlvarez-Buylla. (2003). Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968-973.
6. Weimann JM, CA Charlton, TR Brazelton, RC Hackman and HM Blau. (2003). Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci USA 100:2088-2093.
7. Weimann JM, CB Johansson, A Trejo and HM Blau. (2003). Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol 5:959-966.
8. Johansson CB, S Youssef, K Koleckar, C Holbrook, R Doyonnas, S Corbel, L Steinman, F Rossi and H Blau. (2008). Extensive fusion of haemotopoietic cells with Purkinje neurons in response to chronic inflammation. Nat Cell Biol 10:575-583.
9. Chen Q, Y Long, X Yuan, L Zou, J Sun, S Chen, JR Perez-Polo and K Yang. (2005). Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res 80:611-619.
10. Caplan AI and JE Dennis. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
11. Rodrigues-Hell RC, MM Silva-Costa, A Miranda-Goes and ALR Oliveira. (2009). Local injection of BDNF producing mesenchymal stem cells increases neuronal survival and synaptic stability following ventral root avulsion. Neurobiol Dis 33:290-300.
12. Constantin G, S Marconi, B Rossi, S Angiari, L Calderan, E Anghileri, B Gini, SD Bach, M Martinello, et al. (2009). Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 27:2624-2635.
13. Brazelton TR, FM Rossi, GI Keshet and HM Blau. (2000). From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290:1775-1779.
14. Bonilla S, A Silva, L Valdés, E Geijo, JM García-Verdugo and S Martínez. (2005). Functional neural stem cells derived from adult bone marrow. Neuroscience 133:85-95.
15. Rivera FJ, S Couillard-Despres, X Pedre, S Ploetz, M Caioni, C Lois, U Bogdahn and L Aigner. (2006). Mesenchymal stem cell instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 24:2209-2219.
16. Wang Y, W Tu, Y Lou, A Xie, X Lai, F Guo and Z Deng. (2009). Mesenchymal stem cells regulate the proliferation and differentiation of neural stem cells through Notch signaling. Cell Biol Int 33:1173-1179.
17. Cabanes C, S Bonilla, L Tabares and S Martínez. (2007). Neuroprotective effect of adult hematopoietic stem cells in a mouse model of motoneuron degeneration. Neurobiol Dis 26:408-418.
18. Pastor D, MC Viso-Leon, J Jones, J Jaramillo-Merchán, JJ Toledo-Aral, JM Moraleda and S Martinez. (2011). Comparative effects between bone marrow and mesenchymal stem cell transplantation in gdnf expression and motor function recovery in a motorneuron degenerative mouse model. Stem Cell Rev 8:445-458.
19. Jones J, J Jaramillo-Merchán, C Bueno, D Pastor, MC Viso-León and S Martínez. (2010). Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia. Neurobiol Dis 40:415-423.
20. Kern S, H Eichler, J Stoeve, H Klü ter and K Bieback. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.
21. Palomo GM, T Cerrato, R Gargini and J Diaz-Nido. (2011). Silencing of frataxin gene expression triggers p53-dependent apoptosis in human neuron-like cells. Hum Mol Genet 20:2807-2822.
22. Huang CY, D Pelaez, J Dominguez-Bendala, F Garcia-Godoy and HS Cheung. (2009). Plasticity of stem cells derived from adult periodontal ligament. Regen Med 4:809-821.
23. Irazusta V, E Obis, A Moreno-Cermeñ o, E Cabiscol, J Ros and J Tamarit. (2010). Yeast frataxin mutants display decreased superoxide dismutase activity crucial to promote protein oxidative damage. Free Radic Biol Med 48:411-420.
24. Marmolino D, M Manto, F Acquaviva, P Vergara, A Ravella, A Monticelli and M Pandolfo. (2010). PGC-1alpha downregulation affects the antioxidant response in Friedreich's ataxia. PLoS One 5:e10025.
25. Mowla SJ, HF Farhadi, S Pareek, JK Atwal, SJ Morris, NG Seidah and RA Murphy. (2001). Biosynthesis and posttranslational processing of the precursor to brain-derived neurotrophic factor. Biol Chem 276:12660-12666.
26. Philo J, J Talvenheimo, J Wen, R Rosenfeld, A Welcher and T Arakawa. (1994). Interactions of neurotrophin-3 (NT-3), brain-derived neurotrophic factor (BDNF), and the NT-3.BDNF heterodimer with the extracellular domains of the TrkB and TrkC receptors. J Biol Chem 269:27840-27846.
27. Coura GS, RC Garcez, CB de Aguiar, M Alvarez-Silva, RS Magini and AG Trentin. (2008). Human periodontal ligament: a niche of neural crest stem cells. J Periodontal Res 43:531-536.
28. Mizuno N, H Shiba, T Inui, K Takeda, M Kajiya, N Hasegawa, H Kawaguchi and H Kurihara. (2008). Effect of neurotrophin-4/5 on bone/cementum-related protein expressions and DNA synthesis in cultures of human periodontal ligament cells. J. Periodont 79:2182-2189.
29. Kemp K, E Mallam, K Hares, J Witherick, N Scolding and A Wilkins. (2011). Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts. PLOS One 6:e26098.
30. Lopatina T, N Kalinina, M Karagyaur, D Stambolsky, K Rubina, A Revishin, G Pavlova, Y Parfyonova and V Tkachuk. (2011). Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo. PLOS One 6:e17899.
31. Tan B, Z Luan, X Wei, Y He, G Wei, BH Johnstone, M Farlow and Y Du. (2011). AMP-activated kinase mediates adipose stem cell-stimulated neuritogenesis of PC12 cells. Neuroscience 181:40-47.
32. Schwartz PM, PR Borghesani, RL Levy, SL Pomeroy and RA Segal. (1997). Abnormal cerebellar development and foliation in BDNF-/-mice reveals a role for neurotrophins in CNS patterning. Neuron 19:269-281.
33. Segal RA, H Takahashi and RD McKay. (1992). Changes in neurotrophin responsiveness during the development of cerebellar granule neurons. Neuron 9:1041-1052.
34. Meng H, S Larson, R Gao and X Qiao. (2007). BDNF transgene improve ataxic and motor behaviors in stargazer mice. Brain Res 1160:47-57.
35. Pardridge WM, YS Kang and JL Buciak. (1994). Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm Res 11: 738-746.
36. Bradley WG, W Hedlund, C Cooper, et al. (1984). A doubleblind controlled trial of bovine brain gangliosides in amyotrophic lateral sclerosis. Neurology 34:1079-1082.
37. The BDNF Study Group (Phase III). (1999). A controlled trial of recombinant methionyl human BDNF in ALS: Neurology 52:1427-1433.
38. Kalra S, A Genge and DL Arnold. (2003). A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Amyotroph Lateral Scler Other Motor Neuron Disord 4: 22-26.
39. Beck M, P Flachenecker, T Magnus, R Giess, K Reiners, KV Toyka and M Naumann. (2005). Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph Lateral Scler Other Motor Neuron Disord 6: 100-103.
40. Li CQ, JM Xu, D Liu, JY Zhang and RP Dai. (2008). Brain derived neurotrophic factor (BDNF) contributes to the pain hypersensitivity following surgical incision in the rats. Mol Pain 4:27-37.